MIC:GEMA (Russia)
Â
Ordinary Shares
₽
170.75
(+2.4%)
Jun 7
Current and historical daily PE Ratio for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (
MIC:GEMA
) from 2019 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC stock (MIC:GEMA) PE ratio as of Jun 10 2024 is 48.56.
More Details
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) PE Ratio (TTM) Chart
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) PE Ratio (TTM) Historical Data
View and export this data going back to 2019. Start your Free Trial
Total 1237
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 49.7 | 2024-04-05 | 49.9 |
| 2024-06-07 | 49.7 | 2024-04-04 | 50.1 |
| 2024-06-06 | 48.6 | 2024-04-03 | 50.4 |
| 2024-06-05 | 49.6 | 2024-04-02 | 50.7 |
| 2024-06-04 | 49.9 | 2024-04-01 | 51.4 |
| 2024-06-03 | 46.4 | 2024-03-29 | 50.8 |
| 2024-05-31 | 48.4 | 2024-03-28 | 50.4 |
| 2024-05-30 | 50.4 | 2024-03-27 | 51.2 |
| 2024-05-29 | 49.6 | 2024-03-26 | 51.5 |
| 2024-05-28 | 50.2 | 2024-03-25 | 52.1 |
| 2024-05-27 | 49.7 | 2024-03-22 | 50.8 |
| 2024-05-24 | 51.1 | 2024-03-21 | 52.7 |
| 2024-05-23 | 52.8 | 2024-03-20 | 52.7 |
| 2024-05-22 | 53.2 | 2024-03-19 | 53.1 |
| 2024-05-21 | 51.7 | 2024-03-18 | 54.6 |
| 2024-05-20 | 53.3 | 2024-03-15 | 55.2 |
| 2024-05-17 | 53.9 | 2024-03-13 | 56.5 |
| 2024-05-16 | 53.7 | 2024-03-12 | 57.0 |
| 2024-05-15 | 54.7 | 2024-03-11 | 57.7 |
| 2024-05-14 | 54.8 | 2024-03-07 | 57.4 |
| 2024-05-13 | 55.6 | 2024-03-06 | 57.2 |
| 2024-05-10 | 55.8 | 2024-03-05 | 58.2 |
| 2024-05-08 | 56.1 | 2024-03-04 | 59.4 |
| 2024-05-07 | 59.2 | 2024-03-01 | 57.7 |
| 2024-05-06 | 60.8 | 2024-02-29 | 59.3 |
| 2024-05-03 | 57.2 | 2024-02-28 | 54.0 |
| 2024-05-02 | 53.6 | 2024-02-27 | 49.1 |
| 2024-04-30 | 54.7 | 2024-02-26 | 50.1 |
| 2024-04-29 | 56.1 | 2024-02-22 | 55.9 |
| 2024-04-27 | 56.8 | 2024-02-15 | 67.4 |
| 2024-04-26 | 57.8 | 2024-02-14 | 73.3 |
| 2024-04-25 | 60.0 | 2024-02-13 | 66.7 |
| 2024-04-24 | 54.6 | 2024-02-12 | 60.7 |
| 2024-04-23 | 56.2 | 2024-02-09 | 55.3 |
| 2024-04-22 | 62.3 | 2024-02-08 | 45.4 |
| 2024-04-19 | 56.7 | 2024-02-01 | 372.2 |
| 2024-04-18 | 46.6 | 2024-01-31 | 354.8 |
| 2024-04-17 | 46.6 | 2024-01-30 | 345.4 |
| 2024-04-16 | 47.3 | 2024-01-29 | 337.2 |
| 2024-04-15 | 48.2 | 2024-01-26 | 330.2 |
| 2024-04-12 | 48.5 | 2024-01-25 | 315.2 |
| 2024-04-11 | 49.1 | 2024-01-24 | 313.5 |
| 2024-04-10 | 49.6 | 2024-01-23 | 311.4 |
| 2024-04-09 | 49.4 | 2024-01-22 | 306.6 |
| 2024-04-08 | 49.8 | 2024-01-19 | 305.3 |
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC
ISIN : RU000A100GC7
Share Class Description:
MIC:GEMA: Ordinary SharesDescription
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation and Umbilical cord tissue among others.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers